Using Facebook to Support Opioid Recovery Among American Indian Women

May 5, 2026 updated by: Christi Patten, Mayo Clinic

Facebook Intervention for Preventing Opioid Relapse Among American Indian Women: Wiidookaage'Win Pilot Preparatory Study (Aim 2)

The purpose of this study is to find out whether a Facebook group will help Native women in recovery from opioid use.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. AIAN person based on self-reported race/ethnicity
  2. Gender identity as a woman
  3. At least 18 years of age with no upper age limit
  4. Resides in Minnesota
  5. Meets criteria for OUD based on the DSM-5 Checklist (American Psychiatric Association, 2013)
  6. Self-reports at least one month of abstinence from opioid use based on TLFB interview and negative urine opiate screen
  7. Current use of MOUD
  8. Is comfortable speaking and reading English
  9. Has an existing Facebook account or willing to set one up
  10. Is willing and able to participate in the Facebook intervention for 3 months
  11. Has access to broadband internet on a mobile phone/computer/tablet at any location
  12. Is willing and able to travel to a community clinic in Minneapolis, Minnesota for the UDS or is willing to and able to complete a virtual Zoom UDS visit.
  13. Provides written informed consent

Exclusion Criteria:

  1. Self-reports current suicidality based on the Concise Heath Risk Tracking scale
  2. Participated in prior study phases (Aim 1 formative work) of NIDA CTN-0123

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Wiidookaage'win Facebook Group
The Wiidookaage'win Facebook Group is an online, asynchronous group intervention that will run for 3-months with approximately 30 days of content developed. It is private and hidden, meaning only those in the study will be able to see or find the group. It will be moderated by two women from the study team (one AIAN and one biracial). A back-up moderator will also have access to the group. Participants will be able to comment, react, view, and post in the intervention group, and are encouraged to interact with one another.
Behavioral: Wiidookaage'win Facebook Group
An online social media group program that incorporates social support, mindfulness-based, and cultural practices that may support OUD recovery.
No Intervention: Online Resources Landing Page
The Online Resources Landing Page was developed by the study team using https://carrd.co. It includes links to local programs in family services, substance use recovery, legal advocacy, etc. which already exist and may help support their recovery.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feasibility of Facebook Intervention
Time Frame: 3 months
The study team will measure the feasibility from the combined reports of recruitment, study retention, level of Facebook intervention uptake/engagement, and treatment satisfaction.
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Timeline Follow-back Interview and UDS to measure Opioid Abstinence
Time Frame: 6 months
The study team will explore the preliminary differential impact of the intervention compared with the control condition on opioid abstinence and MOUD continuation. Opioid and other substance use will be assessed through monthly Timeline Follow-Back (TLFB) interviews (Sobell & Sobell, 1992; Wray et al., 2016). At 1, 3, and 6-months, the study team will obtain a UDS that will be used along with the TLFB interviews to measure opioid abstinence.
6 months
Reporting MOUD continuation
Time Frame: 6 months
The study team will summarize MOUD continuation as the proportion of participants reporting current use at 6-month follow-up.
6 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Perceived Stress Scale and Communal Mastery Scale
Time Frame: 3 months
The study team will explore the differential impact of the intervention compared with the control condition on constructs targeted by our intervention, specifically perceived stress and coping with stressful life circumstances from a more collectivist orientation, respectively.
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Mayo Clinic

Collaborators

National Institute on Drug Abuse (NIDA)

Investigators

  • Principal Investigator: Christi A Patten, PhD, Mayo Clinic

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 16, 2023

Primary Completion (Estimated)

August 15, 2026

Study Completion (Estimated)

October 25, 2026

Study Registration Dates

First Submitted

August 1, 2023

First Submitted That Met QC Criteria

August 10, 2023

First Posted (Actual)

August 16, 2023

Study Record Updates

Last Update Posted (Actual)

May 7, 2026

Last Update Submitted That Met QC Criteria

May 5, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 23-005038
  • DA40316-08S2 (Other Grant/Funding Number: National Institute on Drug Abuse)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Opioid Use Disorder

Clinical Trials on Wiidookaage'win Facebook Group

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Nigeria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe